SQLite Web: event_store.db

Update row sig_e6a1b06a2e63 in signals

id

Primary key. TEXT

event_id

TEXT NOT NULL

watcher_id

TEXT

signal_type

TEXT NOT NULL

value

{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1708599/0001329505-26-000002.txt","as_of":"2026-04-22T03:03:32.063787+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1708599/0001329505-26-000002.txt","company":"Serina Therapeutics, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1708599/0001329505-26-000002.txt","article_chars":1616,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_cc2e657099d9dad8","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1708599/0001329505-26-000002.txt","content_type":"text/plain","enriched_at":"2026-04-22T03:31:29.393246+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1708599/0001329505-26-000002.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1708599/0001329505-26-000002.txt","source_event_id":"evt_d4953d0c208d","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"7c6f2eaf4c2e5a3f","kind":"sec_filing","published_at":"20260421","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-21","2026-03-31","2025-04-08","2017-06-06"],"entities":[{"asset_class":"equity","name":"Serina Therapeutics, Inc.","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"person","name":"Bailey Gregory","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"preferred_equity","name":"Series A Convertible Preferred Stock","relevance":"medium","symbol":"","type":"security"},{"asset_class":"equity","name":"Common Stock","relevance":"medium","symbol":"","type":"security"}],"event_type":"other","information_gaps":["What changed vs prior known state is not provided in the signal; no prior filing/position is included for comparison.","The text snippet includes numeric fields (e.g., 59667, 1.94, 126910) but does not explicitly label them as shares/price/consideration in a way that can be fully verified from the provided excerpt.","No explicit statement of whether the reporting owner\u2019s holdings increased/decreased beyond the issuance description is provided.","No transaction type code details (e.g., whether it is a conversion) are explicitly described beyond the dividend-payment issuance statement."],"key_facts":["SEC filing type: Form 4.","Issuer: Serina Therapeutics, Inc. (SEC file number 001-38519).","Reporting owner: Bailey Gregory.","Conformed period of report: 2026-03-31.","Filed as of date: 2026-04-21.","The filing states: \u201cThese shares of common stock were issued for payment of accrued dividends on the reporting individuals Series A Convertible Preferred Stock issued on April 8, 2025.\u201d","The signature line shows \u201c/s/ Gregory Bailey\u201d with date 2026-04-21."],"numeric_claims":[{"label":"Conformed period of report","value":"2026-03-31"},{"label":"Filed as of date","value":"2026-04-21"},{"label":"Series A Convertible Preferred Stock issuance date","value":"2025-04-08"},{"label":"Common stock shares (reported in text as 59667)","value":"59667"},{"label":"Price per share (reported in text as 1.94)","value":"1.94"},{"label":"Total value (reported in text as 126910)","value":"126910"}],"primary_claim":"The Form 4 (filed 2026-04-21) reports that shares of Serina Therapeutics common stock were issued to Bailey Gregory for payment of accrued dividends on Series A Convertible Preferred Stock issued on April 8, 2025.","relevance_score":0.42,"sentiment":"neutral","source_quality":"medium","summary":"Serina Therapeutics, Inc. filed a Form 4 on 2026-04-21 reporting a transaction by reporting owner Bailey Gregory related to common stock issued for accrued dividends. The filing states the shares were issued in connection with Series A Convertible Preferred Stock issued on April 8, 2025.","topics":["SEC Form 4","insider transaction","dividends","convertible preferred stock","share issuance"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 Serina Therapeutics, Inc. \u00b7 Filed 20260421","ticker":"SER","tickers":["SER"],"title":"SER filed 4","url":"https://www.sec.gov/Archives/edgar/data/1708599/0001329505-26-000002.txt"}

TEXT NOT NULL

threshold

TEXT

direction

TEXT

severity

TEXT

window

TEXT

source

TEXT NOT NULL

reason_trace

TEXT

dedupe_key

TEXT NOT NULL

throttle_s

INTEGER (default 0

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

Cancel